Development of 3-nitratomethyl-PROXYL (NMP): A novel, bifunctional superoxide dismutase-mimic-nitric oxide-donor

Drug Development Research

Volumn 50, Issue 3-4, 2000, Pages 528-536

  Haj Yehia, Abdullah ^a   Nassar, Taher ^a   Lotan, Chaim ^a   Münzel, Thomas ^b   Benet, Leslie ^c   Änggard, Erik E ^d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Nitrates; Nitroxides; NO; SOD; Superoxide; Tolerance

Indexed keywords

3 HYDROXYMETHYL 2,2,5,5 TETRAMETHYL 1 PYRROLIDINYLOXY; 3 NITRATOMETHYL 2,2,5,5 TETRAMETHYL 1 PYRROLIDINYLOXY; GLYCERYL TRINITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; ORGANIC NITRATE; SUPEROXIDE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CROSS TOLERANCE; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; NONHUMAN; OXIDATIVE STRESS; RAT; REBOUND; REVIEW;

EID: 0033819794     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200007/08)50:3/4<528::AID-DDR36>3.0.CO;2-3     Document Type: Review

References (92)

1. A reappraisal of nitrate therapy
2. Organic nitrate esters: Clinical use and mechanisms of actions
3. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and alteration in cGMP turnover
4. Suppression of nitrate tolerance by vitamin C and other antioxidants
5. Pathological implication of nitric oxide, superoxide and peroxynitrite formation
6. Apparent hydroxyl radical production by peroxynitrite: Implication for endothelial injury, from nitric oxide and superoxide
7. Biotransformation of organic nitrates and vascular smooth muscle cell function
8. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels
9. Biochemical and pharmacological interactions between nitroglycerin and thiols. Effects of thiol structure on nitric oxide generation and tolerance reversal
10. Conversion of nitroglycerin to nitric oxide in microcosms of the bovine coronary artery smooth muscle is not primarily mediated by glutathione S-transferases
11. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease
12. Reactions of OH?
13. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohormonal activation and lack of prevention with N-acetylcysteine
14. Tolerance to organic nitrates: Evidence, mechanisms, clinical relevance, and strategies for prevention
15. The biochemical pathway of nitric oxide formation from nitrovasodilators: Appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions
16. Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators
17. Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle cells and endothelial cells
18. Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation
19. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor
20. The obligatory, role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
21. Glutamate, nitric oxide and cell-cell signaling in the nervous system
22. Cardiac reperfusion damage prevented by a nitroxide free radical
23. The neurotransmitter of the non-adrenergic non-cholinergic inhibitory nerves to smooth muscle of the genital system
24. 2·: A pulse radiolysis study
25. The Fenton reagents
26. Angiotensin II stimulates NADH oxidase activity in cultured vascular smooth muscle cells
27. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
28. Glutathione S-transferase mu polymorphism does not explain variation in nitroglycerin responsiveness
29. Dissociation of tissue thiol content from nitroglycerin-induced cGMP increase and the state of tolerance. In vivo experiments in rats
30. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: A thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance
31. The nitrovasodilators: New ideas about old drugs
32. The inactivation of copper-zinc superoxide dismutase by diethyldithiocarbarnate
33. Overview of cytotoxic mechanisms and defense of the intracellular environment against microbes
34. Nitric oxide: A cytotoxic activated macrophage effector molecule
35. Superoxide initiates oxidation of low-density lipoprotein by human monocytes
36. The reaction of NO with superoxide
37. Biosynthesis and metabolism of endothelium-derived nitric oxide
38. Heme-dependent activation of guanylate cyclase by nitric oxide: A novel signal transduction mechanism
39. Endothelium-derived relaxing factor is nitric oxide
40. Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery disease
41. Extracellular superoxide dismutase in the vascular system of mammals
42. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor activity
43. Correlation of the response to nitroglycerin in rabbit aorta with the activity of the mu class glutathione S-transferase
44. Nitroxides as antioxidants
45. - formation
46. A role for angiotensin II in nitrate tolerance: Chronic AT-1 receptor blockade prevents development of tolerance and cross-tolerance
47. Effects of antioxidants on tolerance to glyceryl trinitrate
48. Lack of evidence for the involvement of cytochrome p450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta
49. Endothelium-derived nitric oxide: The endogenous nitrovasodilator in human cardiovascular system
50. Direct electrochemical measurement of nitric oxide released from human platelets
51. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture
52. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate
53. Biotransformation of glyceryl trinitrate by rat aortic cytochrome p450
54. Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate
55. Biologically active metal-independent superoxide dismutase mimics
56. The L-arginine-nitric oxide pathway
57. Biosynthesis of nitric oxide from L-arginine: A pathway for the regulation of cell function and communication
58. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide activity
59. Identification of the membrane bound NADH oxidase as the major source of superoxide anion in nitrate tolerance
60. Evidence for a role of endothelin-1 and protein kinase C in nitrate tolerance
61. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: A novel mechanism of tolerance and cross tolerance
62. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin infusion in patients with coronary artery disease
63. New insights into mechanisms underlying nitrate tolerance
64. EDRF is an intracellular messenger and autocoid to regulate cyclic GMP synthesis in many cells
65. Role of nitric oxide synthesis in macrophage antimicrobial activity
66. Mechanism of tolerance development to organic nitrates
67. DNA damage and mutation in human cells exposed to nitric oxide in vivo
68. Inflammation, immunoregulation and inducible nitric oxide synthase
69. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and independent nitrovasodilator relaxation
70. 2 toxicity
71. Nitric oxide release accounts for biological activity of endothelium-derived relaxing factor
72. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin
73. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide
74. Nitrergic transmission: Nitric oxide as a mediator of non-adrenergic non-cholinergic neuro-effector transmission
75. Superoxide anions enhance platelet adhesion and aggregation
76. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage
77. 2α
78. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide
79. Cytochrome p450 mediates bioactivation of organic nitrates
80. Alteration in human vascular endothelial cell function by oxygen free radical. Platelet adherence and prostacyclin release
81. Biological roles of nitric oxide
82. Altered spectrum of nitroglycerin action in long-term treatment: Nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency
83. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and chemical reactivity of nitric oxide
84. Pharmacokinetics and metabolism of organic nitrate vasodilators
85. Nitric oxide and the regulation of cerebral arterial tone
86. Mechanisms of action of nitrates
87. Regulatory functions of the vascular endothelium
88. Endothelium and control of vascular function
89. Desensitization to nitroglycerin in vascular smooth muscle from rat and human
90. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance
91. The reaction between organic nitrates and sulfhydryl compounds. A possible model system for activation of organic nitrates